Chronic conditions resources

A list of resources – including apps, audio and video resources and other publications – about chronic conditions.

Resources

Life Saving Drugs Program – Mucopolysaccharidosis type VI (MPS VI) – Reapplication

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for MPS VI.

Life Saving Drugs Program – Fabry disease – Initial application

Treating physicians use this application form to apply for a patient to access LSDP medication for Fabry disease for the first time, or after a break.

Providing health care to a thalidomide survivor fact sheet

This fact sheet is designed to help facilitate discussions between thalidomide survivors and their health care practitioners.

Chronic health plans – Easy Read

This fact sheet tells you about health care plans for chronic health problems. Chronic means something lasts a long time. Chronic health problems last a long time. You can download the fact sheet in PDF to read online or print.

Life Saving Drugs Program – PNH – Review summary and Expert Panel recommendations

This PNH review considered eculizumab. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

Life Saving Drugs Program – PNH – Review summary and Expert Panel recommendations for consumers

This PNH review considered eculizumab. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

Life Saving Drugs Program – HT1 – Review summary and Expert Panel recommendations

This HT1 review considered nitisinone (only the brand Orfadin® was in scope for the review). The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.

Life Saving Drugs Program – HT1 – Review summary and Expert Panel recommendations for consumers

This HT1 review considered nitisinone (only the brand Orfadin® was in scope for the review). The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

Life Saving Drugs Program – Change of treating physician form

Use this form to help transition a patient’s care to a new physician, where there are no other changes to their treatment or eligibility for the Life Saving Drugs Program (LDSP).
3:58

Using the bowel screening home test kit

Bowel screening can save your life. Find out how to do the test when you receive your screening kit in the mail.
Last updated:

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.